0093-1135

Generic: acitretin

Labeler: teva pharmaceuticals usa, inc.
NDC Directory DRUG FOR FURTHER PROCESSING DRUG FOR FURTHER PROCESSING Active

Drug Facts

Product Profile

Brand Name
Generic Name acitretin
Labeler teva pharmaceuticals usa, inc.
Dosage Form CAPSULE
Active Ingredients

acitretin 10 mg/1

Identifiers & Regulatory

Product NDC 0093-1135
Product ID 0093-1135_f1ee1166-0c8e-4302-a3ca-7d498b2e646d
Product Type DRUG FOR FURTHER PROCESSING
Marketing Category DRUG FOR FURTHER PROCESSING
Listing Expiration 2026-12-31
Marketing Start 2021-11-01

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00931135
Hyphenated Format 0093-1135

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acitretin (source: label)
Generic Name acitretin (source: ndc)
Application Number ANDA091455 (source: label)
Routes
oral
source: label

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 20000 CAPSULE in 1 BOX (0093-1135-00)
source: ndc

Packages (1)

0093-1135-00 20000 CAPSULE in 1 BOX (0093-1135-00)

Ingredients (1)

acitretin (10 mg/1)

Linked Drug Pages (1)

Acitretin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "f1ee1166-0c8e-4302-a3ca-7d498b2e646d", "openfda": {}, "finished": false, "packaging": [{"description": "20000 CAPSULE in 1 BOX (0093-1135-00)", "package_ndc": "0093-1135-00", "marketing_start_date": "01-NOV-21"}], "product_id": "0093-1135_f1ee1166-0c8e-4302-a3ca-7d498b2e646d", "dosage_form": "CAPSULE", "product_ndc": "0093-1135", "generic_name": "Acitretin", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "ACITRETIN", "strength": "10 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20211101", "listing_expiration_date": "20261231"}